澳华内镜:2025一季报净利润-0.29亿 同比下降1066.67%

Financial Performance - The company reported a basic earnings per share of -0.2100 yuan for Q1 2025, a decrease of 1150% compared to 0.0200 yuan in Q1 2024 [1] - Net profit for Q1 2025 was -0.29 billion yuan, a significant decline of 1066.67% from 0.03 billion yuan in Q1 2024 [1] - Operating revenue decreased by 26.63% to 1.24 billion yuan in Q1 2025 from 1.69 billion yuan in Q1 2024 [1] - The return on equity was -2.13% in Q1 2025, down from 0.19% in Q1 2024, indicating a substantial decline in profitability [1] Shareholder Structure - The top ten unrestricted shareholders hold a total of 64.21 million shares, accounting for 47.69% of the circulating shares, with a decrease of 757,400 shares compared to the previous period [2] - Major shareholders include Gu Xiaozhou with 21.74 million shares (16.14%), and Gu Kang with 16.95 million shares (12.59%), both remaining unchanged [3] - New entrants in the top ten shareholders include a fund from China Construction Bank holding 2.05% of the total shares, while two previous shareholders exited the top ten list [3] Dividend Policy - The company has announced that it will not distribute dividends or bonuses this period [4]